Skip to content

A study for the intervention of Xiangxue antiviral oral solution and Wu-Zhi-Fang-Guan-Fang on close contacts of novel coronavirus pneumonia (COVID-19)

A study for the intervention of Xiangxue antiviral oral solution and Wu-Zhi-Fang-Guan-Fang on close contacts of novel coronavirus pneumonia (COVID-19)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030033
Enrollment
Unknown
Registered
2020-02-21
Start date
2020-02-24
Completion date
Unknown
Last updated
2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Intervention group 1:Oral antiviral oral solution (Xiangxue Pharmaceutical)
Intervention group 2:Oral "Wu-Zhi-Fang-Guan-Fang" decoction
Control group:Routine quarantine measures

Sponsors

The First Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 80 years (inclusive); 2. People who had ineffective protection, i.e.: 1) living, studying, working together with, or having close contacts with confirmed cases and positive testers, such as working at close distances or sharing the same classroom or living in the same house; 2) had close contacts with medical personnel, family members or people who have similar close contact during the diagnosis, treatment, and visits, such as visiting or staying in a closed environment with other patients in the ward and their accompanying staff personnel; 3) people who took the same transportation and have close contact with the cases, including carers on the transportation vehicle; 4) people traveled together (e.g., family, colleagues, friends, etc.); 5) Other passengers or flight attendants who possibly had close contact with confirmed cases and positive testers after investigation and evaluation; 3. People who were considered as having close contacts with cases after an assessment by onsite investigators.

Exclusion criteria

Exclusion criteria: 1. The physician decides that participating in this study is not in the best interest of the subject or that there exist a circumstance in which the agreed protocol cannot be safely followed; 2. People who have allergic reactions or allergies to antiviral oral solution or Wuzhifangguanfang decoction; 3. Those who do not meet the national diagnostic criteria for close contacts of new coronary pneumonia; 4. Confirmed cases of new coronavirus pneumonia; 5. People with mental disorders who cannot communicate normally; 6. Pregnant woman; 7. People who do not agree to participate;

Design outcomes

Primary

MeasureTime frame
Proportion of COVID-19 close contacts who have developed as confirmed cases;

Countries

Chinese

Contacts

Public ContactFeng WANG

The First Affiliated Hospital of Guangzhou Medical University

412475734@qq.com+86 13710801606

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026